These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27410255)

  • 1. Two Good Read-across Practice workshops. Making it work for you!
    Maertens A; Hubesch B; Rovida C
    ALTEX; 2016; 33(3):324-6. PubMed ID: 27410255
    [No Abstract]   [Full Text] [Related]  

  • 2. REACH testing requirements must not be driven by reproductive toxicity testing.
    Spielmann H; Vogel R
    Altern Lab Anim; 2006 Aug; 34(4):365-6. PubMed ID: 16945004
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence-Based Toxicology Collaboration (EBTC). Editorial.
    von Aulock S
    ALTEX; 2013; 30(1):1. PubMed ID: 23451363
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel strategies for toxicological risk assessments.
    Roy A; Akbarsha MA
    ALTEX; 2014; 31(1):91-3. PubMed ID: 24448760
    [No Abstract]   [Full Text] [Related]  

  • 5. Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals.
    Crofton KM; Mundy WR; Lein PJ; Bal-Price A; Coecke S; Seiler AE; Knaut H; Buzanska L; Goldberg A
    ALTEX; 2011; 28(1):9-15. PubMed ID: 21311847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of mechanistic categories and local models to facilitate the prediction of toxicity.
    Cronin MT; Enoch SJ; Hewitt M; Madden JC
    ALTEX; 2011; 28(1):45-9. PubMed ID: 21311849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity testing: the need for new maps for the future.
    Balls M
    Altern Lab Anim; 2011 Oct; 39(5):417-8. PubMed ID: 22103936
    [No Abstract]   [Full Text] [Related]  

  • 8. Introduction to the EU REACH legislation.
    Grindon C; Combes R
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():5-10. PubMed ID: 16555955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternatives to the use of animals in research, education and testing.
    Macharia Theuri S; Ngonyo J; Wangari Kagai M
    ALTEX; 2016; 33(2):183-5. PubMed ID: 27032089
    [No Abstract]   [Full Text] [Related]  

  • 10. Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation.
    Höfer T; Gerner I; Gundert-Remy U; Liebsch M; Schulte A; Spielmann H; Vogel R; Wettig K
    Arch Toxicol; 2004 Oct; 78(10):549-64. PubMed ID: 15170526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of skin sensitizers using alternative methods to animal experimentation.
    Johansson H; Lindstedt M
    Basic Clin Pharmacol Toxicol; 2014 Jul; 115(1):110-7. PubMed ID: 24548737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SEURAT: Safety Evaluation Ultimately Replacing Animal Testing--recommendations for future research in the field of predictive toxicology.
    Daston G; Knight DJ; Schwarz M; Gocht T; Thomas RS; Mahony C; Whelan M
    Arch Toxicol; 2015 Jan; 89(1):15-23. PubMed ID: 25433540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International STakeholder NETwork (ISTNET) for creating a developmental neurotoxicity testing (DNT) roadmap for regulatory purposes.
    Crofton K; Fritsche E; Ylikomi T; Bal-Price A
    ALTEX; 2014; 31(2):223-4. PubMed ID: 24794006
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemical respiratory allergy: opportunities for hazard identification and characterisation. The report and recommendations of ECVAM workshop 60.
    Kimber I; Agius R; Basketter DA; Corsini E; Cullinan P; Dearman RJ; Gimenez-Arnau E; Greenwell L; Hartung T; Kuper F; Maestrelli P; Roggen E; Rovida C;
    Altern Lab Anim; 2007 May; 35(2):243-65. PubMed ID: 17559314
    [No Abstract]   [Full Text] [Related]  

  • 15. A review of the status of alternative approaches to animal testing and the development of integrated testing strategies for assessing the toxicity of chemicals under REACH--a summary of a DEFRA-funded project conducted by Liverpool John Moores University and FRAME.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():149-58. PubMed ID: 16555968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance and Application of Read-Across - Mini Review of European Consensus Platform for Alternatives and Scandinavian Society for Cell Toxicology 2017 Workshop Session.
    Stuard SB; Heinonen T
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():37-41. PubMed ID: 29524304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using toxicological evidence from QSAR models in practice.
    Benfenati E; Pardoe S; Martin T; Gonella Diaza R; Lombardo A; Manganaro A; Gissi A
    ALTEX; 2013; 30(1):19-40. PubMed ID: 23338804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional cell cultures in toxicology.
    Pampaloni F; Stelzer E
    Biotechnol Genet Eng Rev; 2010; 26():117-38. PubMed ID: 21415878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and strategic use of alternative tests in assessing the hazard of chemicals.
    Purchase IF
    Arch Toxicol Suppl; 1998; 20():71-80. PubMed ID: 9442283
    [No Abstract]   [Full Text] [Related]  

  • 20. Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluation.
    Bal-Price AK; Coecke S; Costa L; Crofton KM; Fritsche E; Goldberg A; Grandjean P; Lein PJ; Li A; Lucchini R; Mundy WR; Padilla S; Persico AM; Seiler AE; Kreysa J
    ALTEX; 2012; 29(2):202-15. PubMed ID: 22892558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.